Cargando…

Dosimetric Comparison and Feasibility of Simultaneous Integrated Boost (SIB) in Treatment of Malignant Gliomas Using Intensity Modulated Radiotherapy (IMRT) or Volumetric Modulated Arc Therapy (VMAT)

OBJECTIVE: To evaluate the dosimetric parameters of Simultaneous Integrated Boost in the treatment of malignant gliomas and compare the SIB plans of VMAT and IMRT. METHODOLOGY: CT and MRI of 28 patients were used for generating SIB plans with VMAT and IMRT. A dose of 2Gy per fraction was prescribed...

Descripción completa

Detalles Bibliográficos
Autores principales: Rapole, Pragna Sagar, Karunanithi, Gunaseelan, Kandasamy, Saravanan, Prabhu, Sathiya, Kumar, Ram, Vivekanandam, S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: West Asia Organization for Cancer Prevention 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6249485/
https://www.ncbi.nlm.nih.gov/pubmed/30256043
http://dx.doi.org/10.22034/APJCP.2018.19.9.2499
_version_ 1783372760601329664
author Rapole, Pragna Sagar
Karunanithi, Gunaseelan
Kandasamy, Saravanan
Prabhu, Sathiya
Kumar, Ram
Vivekanandam, S
author_facet Rapole, Pragna Sagar
Karunanithi, Gunaseelan
Kandasamy, Saravanan
Prabhu, Sathiya
Kumar, Ram
Vivekanandam, S
author_sort Rapole, Pragna Sagar
collection PubMed
description OBJECTIVE: To evaluate the dosimetric parameters of Simultaneous Integrated Boost in the treatment of malignant gliomas and compare the SIB plans of VMAT and IMRT. METHODOLOGY: CT and MRI of 28 patients were used for generating SIB plans with VMAT and IMRT. A dose of 2Gy per fraction was prescribed to the CPTV and 2.4Gy to the GPTV for a total of 25 fractions. The plans were accepted only if they met the set of planning objectives defined in the protocol. RESULTS: We could achieve the planning objectives in all the SIB plans. Although GPTV coverage was statistically better in VMAT (98.67% vs 98.19% ;p=0.024) the difference is not clinically meaningful. The conformity index for GPTV was higher in IMRT (0.83 vs 0.76; p=0.001). The coverage of CPTV was better in IMRT (97.88% vs 96.87%; p=0.021). But the conformity index of CPTVannulus was higher in VMAT (0.72 vs 0.67; p=0.01). There was no difference in homogeneity index of GPTV and CPTV annulus between the plans. The mean dose received by normal brain was higher in IMRT (28Gy vs 24.2Gy; p<0.001). Ipsilateral optic nerve has received lesser Dmax in IMRT (44.2Gy vs 46.95Gy; p=0.02). No difference was seen in Dmax of brainstem, optic chiasm, contralateral optic nerve. The treatment times and monitor units were significantly less in VMAT. CONCLUSION: SIB is dosimetrically feasible for hypofractionation in malignant gliomas using IMRT and VMAT. IMRT plans had better boost conformity, lower ipsilateral optic nerve and brainstem maximum doses compared to VMAT. Whereas, VMAT had better coverage, better overall PTV conformity, lower normal brain mean dose, lower monitor units and lesser treatment times. Although planning of VMAT is cumbersome and time consuming, the advantage of reducing treatment time is beneficial to the patients’ comfort and better managing of patient load in high volume centres.
format Online
Article
Text
id pubmed-6249485
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher West Asia Organization for Cancer Prevention
record_format MEDLINE/PubMed
spelling pubmed-62494852018-12-07 Dosimetric Comparison and Feasibility of Simultaneous Integrated Boost (SIB) in Treatment of Malignant Gliomas Using Intensity Modulated Radiotherapy (IMRT) or Volumetric Modulated Arc Therapy (VMAT) Rapole, Pragna Sagar Karunanithi, Gunaseelan Kandasamy, Saravanan Prabhu, Sathiya Kumar, Ram Vivekanandam, S Asian Pac J Cancer Prev Research Article OBJECTIVE: To evaluate the dosimetric parameters of Simultaneous Integrated Boost in the treatment of malignant gliomas and compare the SIB plans of VMAT and IMRT. METHODOLOGY: CT and MRI of 28 patients were used for generating SIB plans with VMAT and IMRT. A dose of 2Gy per fraction was prescribed to the CPTV and 2.4Gy to the GPTV for a total of 25 fractions. The plans were accepted only if they met the set of planning objectives defined in the protocol. RESULTS: We could achieve the planning objectives in all the SIB plans. Although GPTV coverage was statistically better in VMAT (98.67% vs 98.19% ;p=0.024) the difference is not clinically meaningful. The conformity index for GPTV was higher in IMRT (0.83 vs 0.76; p=0.001). The coverage of CPTV was better in IMRT (97.88% vs 96.87%; p=0.021). But the conformity index of CPTVannulus was higher in VMAT (0.72 vs 0.67; p=0.01). There was no difference in homogeneity index of GPTV and CPTV annulus between the plans. The mean dose received by normal brain was higher in IMRT (28Gy vs 24.2Gy; p<0.001). Ipsilateral optic nerve has received lesser Dmax in IMRT (44.2Gy vs 46.95Gy; p=0.02). No difference was seen in Dmax of brainstem, optic chiasm, contralateral optic nerve. The treatment times and monitor units were significantly less in VMAT. CONCLUSION: SIB is dosimetrically feasible for hypofractionation in malignant gliomas using IMRT and VMAT. IMRT plans had better boost conformity, lower ipsilateral optic nerve and brainstem maximum doses compared to VMAT. Whereas, VMAT had better coverage, better overall PTV conformity, lower normal brain mean dose, lower monitor units and lesser treatment times. Although planning of VMAT is cumbersome and time consuming, the advantage of reducing treatment time is beneficial to the patients’ comfort and better managing of patient load in high volume centres. West Asia Organization for Cancer Prevention 2018 /pmc/articles/PMC6249485/ /pubmed/30256043 http://dx.doi.org/10.22034/APJCP.2018.19.9.2499 Text en Copyright: © Asian Pacific Journal of Cancer Prevention http://creativecommons.org/licenses/BY-SA/4.0 This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
spellingShingle Research Article
Rapole, Pragna Sagar
Karunanithi, Gunaseelan
Kandasamy, Saravanan
Prabhu, Sathiya
Kumar, Ram
Vivekanandam, S
Dosimetric Comparison and Feasibility of Simultaneous Integrated Boost (SIB) in Treatment of Malignant Gliomas Using Intensity Modulated Radiotherapy (IMRT) or Volumetric Modulated Arc Therapy (VMAT)
title Dosimetric Comparison and Feasibility of Simultaneous Integrated Boost (SIB) in Treatment of Malignant Gliomas Using Intensity Modulated Radiotherapy (IMRT) or Volumetric Modulated Arc Therapy (VMAT)
title_full Dosimetric Comparison and Feasibility of Simultaneous Integrated Boost (SIB) in Treatment of Malignant Gliomas Using Intensity Modulated Radiotherapy (IMRT) or Volumetric Modulated Arc Therapy (VMAT)
title_fullStr Dosimetric Comparison and Feasibility of Simultaneous Integrated Boost (SIB) in Treatment of Malignant Gliomas Using Intensity Modulated Radiotherapy (IMRT) or Volumetric Modulated Arc Therapy (VMAT)
title_full_unstemmed Dosimetric Comparison and Feasibility of Simultaneous Integrated Boost (SIB) in Treatment of Malignant Gliomas Using Intensity Modulated Radiotherapy (IMRT) or Volumetric Modulated Arc Therapy (VMAT)
title_short Dosimetric Comparison and Feasibility of Simultaneous Integrated Boost (SIB) in Treatment of Malignant Gliomas Using Intensity Modulated Radiotherapy (IMRT) or Volumetric Modulated Arc Therapy (VMAT)
title_sort dosimetric comparison and feasibility of simultaneous integrated boost (sib) in treatment of malignant gliomas using intensity modulated radiotherapy (imrt) or volumetric modulated arc therapy (vmat)
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6249485/
https://www.ncbi.nlm.nih.gov/pubmed/30256043
http://dx.doi.org/10.22034/APJCP.2018.19.9.2499
work_keys_str_mv AT rapolepragnasagar dosimetriccomparisonandfeasibilityofsimultaneousintegratedboostsibintreatmentofmalignantgliomasusingintensitymodulatedradiotherapyimrtorvolumetricmodulatedarctherapyvmat
AT karunanithigunaseelan dosimetriccomparisonandfeasibilityofsimultaneousintegratedboostsibintreatmentofmalignantgliomasusingintensitymodulatedradiotherapyimrtorvolumetricmodulatedarctherapyvmat
AT kandasamysaravanan dosimetriccomparisonandfeasibilityofsimultaneousintegratedboostsibintreatmentofmalignantgliomasusingintensitymodulatedradiotherapyimrtorvolumetricmodulatedarctherapyvmat
AT prabhusathiya dosimetriccomparisonandfeasibilityofsimultaneousintegratedboostsibintreatmentofmalignantgliomasusingintensitymodulatedradiotherapyimrtorvolumetricmodulatedarctherapyvmat
AT kumarram dosimetriccomparisonandfeasibilityofsimultaneousintegratedboostsibintreatmentofmalignantgliomasusingintensitymodulatedradiotherapyimrtorvolumetricmodulatedarctherapyvmat
AT vivekanandams dosimetriccomparisonandfeasibilityofsimultaneousintegratedboostsibintreatmentofmalignantgliomasusingintensitymodulatedradiotherapyimrtorvolumetricmodulatedarctherapyvmat